ProImmune Podcasts

Presentations from ProImmune Conferences

Webcasts

 

Podcasts

Short video presentations from the ProImmune team

ProStorm® Cytokine Release Assay
ProT2® MHC Class II Tetramers: Detecting Antigen-specific CD4+ T cells
ProScern®: DC-T Cell Proliferation Assay

ProMap®: Naïve T Cell Proliferation Assay

ProSentium™: The T cell Immuno-Epiproteome at your fingertips
ProImmune REVEAL and ProVE®
Pro5® MHC Pentamers
ProArray Ultra®
HLA Tissue Typing
ProPresent® - ProImmune's Antigen Presentation Assay
The Finance of Immunogenicity

 

ProStorm® Cytokine Release Assay

Back to top

 

ProT2® MHC Class II Tetramers: Detecting Antigen-specific CD4+ T cells

Back to top


ProScern®: DC-T Cell Proliferation Assay

Back to top


ProMap®: Naïve T Cell Proliferation Assay

Back to top


ProSentium™: The T cell Immuno-Epiproteome at your fingertips

Back to top

 

ProImmune REVEAL and ProVE®

Dr Jeremy Fry provides a summary of ProImmune's REVEAL and ProVE® service, the rapid epitope discovery system.

Back to top

 

Pro5® MHC Pentamers

Dr Andrew Waller provides an overview of the Pro5 Pentamer technology and the benefits of using MHC pentamers to detect specific CD8 T Cell populations in your research.

Back to top

 

ProArray Ultra®

Dr Heather Hensler introduces ProArray Ultra®, the high-throughput peptide and protein microarray assay service.

Back to top

 

HLA Tissue Typing

Dr Briana Betz explains the importance of understanding the HLA types of your study cohort, and how ProImmune can help you.

Back to top

 

ProPresent® - ProImmune's Antigen Presentation Assay

Dr Nikolai Schwabe introduces the ProPresent antigen presentation assay and some of its applications in the field of immunogenicity.

Back to top

 

The Finance of Immunogenicity

Managing immunogenicity risk should be a core focus in drug development. ProImmune's CEO Nik Schwabe explains why.

 

Back to top